2014 Annual Meeting | Cerebrovascular Disease and Interventional Neurology: Rehabilitation, Recovery, and Complications

Date Thursday 05/01/14

Time 01:00 PM - 02:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Topic(s) Cerebrovascular Disease and Interventional Neurology

CME Available No CME available

Event Timeline
01:00 PM - 02:45 PM	Abstract	001 - Stroke Survivors with Aphasia May Overestimate Communication Skills: Survivor versus Caregiver Report Vahid Behravan, MD
01:00 PM - 02:45 PM	Abstract	002 - The Association between Meeting Life's Simple 7 Goals and Mortality after Stroke in the US Michelle P. Lin, MD
01:00 PM - 02:45 PM	Abstract	003 - The Amphetamine-Enhanced Stroke Recovery (AESR) Trial: Primary Part 1 Results Larry B. Goldstein, MD, FAHA, FAAN
01:00 PM - 02:45 PM	Abstract	004 - Hospital Factors Associated with Feeding Tube Placement for US Stroke Inpatients Benjamin P. George, MD
01:00 PM - 02:45 PM	Abstract	005 - Utilization of in-hospital palliative care for ischemic stroke deaths in United States
01:00 PM - 02:45 PM	Abstract	006 - Subjective Judgments of Physicians and Nurses Are More Accurate Than Formal Clinical Scales in Predicting Functional Outcome After Intracerebral Hemorrhage David Y. Hwang, MD, FAAN
01:00 PM - 02:45 PM	Abstract	007 - Efficacy of Single and Multiple Injections of Human Umbilical Tissue-Derived Cells Following Experimental Stroke in Rats Amjad Shehadah, MD

Faculty Disclosures
Claire Creutzfeldt, MD	The institution of Dr. Creutzfeldt has received research support from NINDS. The institution of Dr. Creutzfeldt has received research support from NINR.
Randolph S. Marshall, MD, FAAN	The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
	No disclosure on file
Amjad Shehadah, MD	Dr. Shehadah has nothing to disclose.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Michael Chopp, PhD	No disclosure on file
Amy Towfighi, MD	Dr. Towfighi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Towfighi has received research support from NINDS.
Michelle P. Lin, MD	Dr. Lin has nothing to disclose.
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD.
Vahid Behravan, MD	No disclosure on file
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Robert G. Holloway, MD, MPH, FAAN	Dr. Holloway has nothing to disclose.
Dominic Marchese, PharmD, RPh	No disclosure on file
Benjamin P. George, MD	Dr. George has nothing to disclose.
Sebastian Koch, MD	Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.
Carl Langefeld	No disclosure on file
Jennifer Osborne, NP	No disclosure on file
Steven J. Kittner, MD, MPH	The institution of Dr. Kittner has received research support from NINDS.
Adam Kelly, MD, FAAN	Dr. Kelly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grand Rounds/Included Health. Dr. Kelly has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Kelly has received personal compensation in the range of $500-$4,999 for serving as a Question writer for various educational offerings with American Academy of Neurology.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Michael L. James, MD	Dr. James has nothing to disclose.
Daniel Woo, MD, FAAN	Dr. Woo has nothing to disclose.
Jessica McFarlin, MD	Dr. McFarlin has received personal compensation in the range of $500-$4,999 for serving as a Volunteer Faculty with Vital Talk.
Eric B. Schneider, PhD	No disclosure on file
Laura Lennihan, MD, FAAN	No disclosure on file
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from CDC. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Santosh B. Murthy, MD	Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Alexander W. Dromerick, MD	No disclosure on file
Gregory Samsa	No disclosure on file
Michael J. Reding, MD	No disclosure on file
David C. Good, MD, FAAN	Dr. Good has a non-compensated relationship as a President with World Federation for Neurorehabilitation that is relevant to AAN interests or activities.
Meheroz H. Rabadi, MD, FAAN	No disclosure on file
David Y. Hwang, MD, FAAN	Dr. Hwang has received publishing royalties from a publication relating to health care. Dr. Hwang has a non-compensated relationship as a Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Yogesh Moradiya, MD	No disclosure on file
Michael A. Vogelbaum, MD, PhD, FACS	No disclosure on file
Julia Tsai	No disclosure on file
Cinzia Cordioli, MD	Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.